Lymph & Co Consortium Initiation Grant

The aim of the call is to collaborate between multidisciplinary research groups, supplying diverse expertise in consortia working on a joint project. The focus of the call is on the initiation of multidisciplinary consortia working on (therapeutics of) malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). The grant will cover the costs for the organization of an international meeting to initiate the consortium.

Eligibility

Applications from international research groups are welcomed but in particular proposals from scientific groups (national and/or international) with complementing expertise are appreciated.

Applications for funding for organization of the consortium initiation meeting have a maximum of EUR 15.000. It’s a one-time support per consortium.

Evaluation criteria:

• Excellence
  • Clarity and pertinence of the objectives of the consortium
  • Soundness of concept
  • Innovative potential
  • Competence and experience of participating consortium partners
• Impact
  • Potential of the expected results for the future clinical applications including patients’ needs
  • Industry and Patient Organization participation/engagement (when appropriate/applicable)

Contact research@lymph-co.com for official communication with the Research Secretariat.